{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:16:08Z","timestamp":1789398968343,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04112-6","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:38:28Z","timestamp":1758879508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Differences and clinical significance of liver - kidney function parameters, inflammatory markers and peripheral blood T lymphocyte subsets in patients with HBV - related acute - on - chronic liver failure"],"prefix":"10.1186","volume":"25","author":[{"given":"Yongqing","family":"Dou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"4112_CR1","doi-asserted-by":"publisher","unstructured":"Baudi I, Kawashima K, Isogawa M. HBV-Specific CD8\u2009+\u2009T-Cell tolerance in the liver. Front Immunol. 2021;12:721975. https:\/\/doi.org\/10.3389\/fimmu.2021.721975.","DOI":"10.3389\/fimmu.2021.721975"},{"key":"4112_CR2","doi-asserted-by":"publisher","unstructured":"Breuer DA, Pacheco MC, Washington MK, Montgomery SA, Hasty AH, Kennedy AJ. CD8\u2009+\u2009T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol. 2020;318(2):G211\u201324. https:\/\/doi.org\/10.1152\/ajpgi.00040.2019.","DOI":"10.1152\/ajpgi.00040.2019"},{"key":"4112_CR3","doi-asserted-by":"publisher","unstructured":"Cao Z, Liu Y, Wang S, Lu X, Yin S, Jiang S, Chen L, Cai M, Zeng B, Yao Y, Tang W, Zhao G, Xiang X, Wang H, Cai W, Zhu C, Li H, Xie Q. The impact of HBV flare on the outcome of HBV-related decompensated cirrhosis patients with bacterial infection. Liver Int. 2019;39:1943\u201353. https:\/\/doi.org\/10.1111\/liv.14176.","DOI":"10.1111\/liv.14176"},{"key":"4112_CR4","doi-asserted-by":"publisher","unstructured":"Chen RC, Wang XD, Dong JZ, Lin Z, Wu JM, Cai YJ, Shi KQ. A MELD-based nomogram for predicting 3-month mortality of patients with acute-on-chronic hepatitis B liver failure. Clin Chim Acta. 2017;468:195\u2013200. https:\/\/doi.org\/10.1016\/j.cca.2017.03.005.","DOI":"10.1016\/j.cca.2017.03.005"},{"key":"4112_CR5","doi-asserted-by":"publisher","unstructured":"Denner J, Pischke S, Steinmann E, Blumel J, Glebe D. Why all blood donations should be tested for hepatitis E virus (HEV). BMC Infect Dis. 2019;19:541. https:\/\/doi.org\/10.1186\/s12879-019-4190-1.","DOI":"10.1186\/s12879-019-4190-1"},{"key":"4112_CR6","doi-asserted-by":"publisher","unstructured":"European Association for the Study of the Liver. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370\u201398. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.021.","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"4112_CR7","doi-asserted-by":"publisher","unstructured":"Han L, Teng Y, Fan Y, Gao S, Li F, Wang K. Receptor-interacting protein kinase 3 (RIPK3) mRNA levels are elevated in blood mononuclear cells of patients with poor prognosis of acute-on-chronic hepatitis B liver failure. Tohoku J Exp Med. 2019;247:237\u201345. https:\/\/doi.org\/10.1620\/tjem.247.237.","DOI":"10.1620\/tjem.247.237"},{"key":"4112_CR8","doi-asserted-by":"publisher","unstructured":"Hsu YC, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol. 2023;20:524\u201337. https:\/\/doi.org\/10.1038\/s41575-023-00760-9.","DOI":"10.1038\/s41575-023-00760-9"},{"key":"4112_CR9","doi-asserted-by":"publisher","unstructured":"Ichai P, Samuel D. Management of fulminant hepatitis B. Curr Infect Dis Rep. 2019;21:25. https:\/\/doi.org\/10.1007\/s11908-019-0682-9.","DOI":"10.1007\/s11908-019-0682-9"},{"key":"4112_CR10","doi-asserted-by":"publisher","unstructured":"Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Tamura KM, Feldman HI. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2014;63(5):713\u201335. https:\/\/doi.org\/10.1053\/j.ajkd.2014.01.416.","DOI":"10.1053\/j.ajkd.2014.01.416"},{"key":"4112_CR11","doi-asserted-by":"publisher","unstructured":"Jindal A, Vyas A, Sharma M, Kumar G, Sarin SK. A randomized open label trial of Tenofovir monotherapy versus Tenofovir plus Telbivudine in spontaneous reactivation of hepatitis B. Saudi J Gastroenterol. 2019;25:319\u201326. https:\/\/doi.org\/10.4103\/sjg.SJG_537_18.","DOI":"10.4103\/sjg.SJG_537_18"},{"key":"4112_CR12","doi-asserted-by":"publisher","unstructured":"Karimkhanilouyi S, Ghorbian S. Nucleic acid vaccines for hepatitis B and C virus. Infect Genet Evol. 2019;75:103968. https:\/\/doi.org\/10.1016\/j.meegid.2019.103968.","DOI":"10.1016\/j.meegid.2019.103968"},{"key":"4112_CR13","doi-asserted-by":"publisher","unstructured":"Laleman W, Claria J, Van der Merwe S, Moreau R, Trebicka J. Systemic inflammation and Acute-on-Chronic liver failure: too much, not enough. Can J Gastroenterol Hepatol. 2018;2018(1027152). https:\/\/doi.org\/10.1155\/2018\/1027152.","DOI":"10.1155\/2018\/1027152"},{"key":"4112_CR14","doi-asserted-by":"publisher","unstructured":"Lei JH, Peng F, Chen Z, Xiao XQ. Is HBV viral load at admission associated with development of acute-on-chronic liver failure in patients with acute decompensation of chronic hepatitis B related cirrhosis? BMC infect. Dis. 2019;19:363. https:\/\/doi.org\/10.1186\/s12879-019-3988-1.","DOI":"10.1186\/s12879-019-3988-1"},{"key":"4112_CR15","doi-asserted-by":"publisher","unstructured":"Li TP, Guan SH, Wang Q, Chen LW, Yang K, Zhang H. Soluble mannose receptor as a predictor of prognosis of hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol. 2019;25:5667\u201375. https:\/\/doi.org\/10.3748\/wjg.v25.i37.5667.","DOI":"10.3748\/wjg.v25.i37.5667"},{"key":"4112_CR16","doi-asserted-by":"publisher","unstructured":"Li J, Zhang Q, Gao L, Du Y, Chen Y. Efficacy of Decoction from Jieduan Niwan formula on rat model of acute-on-chronic liver failure induced by Porcine serum. J Traditional Chin Med = Chung I Tsa Chih Ying Wen pan. 2020;40(4):602\u201312. https:\/\/doi.org\/10.19852\/j.cnki.jtcm.2020.04.009.","DOI":"10.19852\/j.cnki.jtcm.2020.04.009"},{"key":"4112_CR17","doi-asserted-by":"publisher","unstructured":"Liver Failure and Artificial Liver Group, Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Zhonghua Gan Zang Bing Za zhi. 2025;33(1)18\u201333. https:\/\/doi.org\/10.3760\/cma.j.cn501113-20241206-00614.","DOI":"10.3760\/cma.j.cn501113-20241206-00614"},{"key":"4112_CR18","doi-asserted-by":"publisher","unstructured":"Lu J, Lin L, Ye C, Tao Q, Cui M, Zheng S, Zhu D, Liu L, Xue Y. Serum NGAL is superior to Cystatin C in predicting the prognosis of acute-on-chronic liver failure. Ann Hepatol. 2019;18:155\u201364. https:\/\/doi.org\/10.5604\/01.3001.0012.7907.","DOI":"10.5604\/01.3001.0012.7907"},{"key":"4112_CR19","doi-asserted-by":"publisher","unstructured":"McGlynn EA, Adams JL, Kramer J, Sahota AK, Silverberg MJ, Shenkman E, Nelson DR. Assessing the safety of direct-acting antiviral agents for hepatitis C. JAMA Netw Open. 2019;2:e194765. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.4765.","DOI":"10.1001\/jamanetworkopen.2019.4765"},{"key":"4112_CR20","doi-asserted-by":"publisher","unstructured":"Tan NH, Chen B, Peng J, Du S. Treg\/Th17 cell balance in patients with hepatitis B Virus-Related Acute-on-Chronic liver failure at different disease stages. Biomed Res Int. 2021;2021:9140602. https:\/\/doi.org\/10.1155\/2021\/9140602.","DOI":"10.1155\/2021\/9140602"},{"key":"4112_CR21","doi-asserted-by":"publisher","unstructured":"Tan N, Jian G, Peng J, Tian X, Chen B. Chishao - Fuzi herbal pair restore the macrophage M1\/M2 balance in acute-on-chronic liver failure. J Ethnopharmacol. 2024;328:118010. https:\/\/doi.org\/10.1016\/j.jep.2024.118010.","DOI":"10.1016\/j.jep.2024.118010"},{"key":"4112_CR22","doi-asserted-by":"publisher","unstructured":"Tiegs G, Horst AK. TNF in the liver: targeting a central player in inflammation. Semin Immunopathol. 2022;44(4):445\u201359. https:\/\/doi.org\/10.1007\/s00281-022-00910-2.","DOI":"10.1007\/s00281-022-00910-2"},{"key":"4112_CR23","doi-asserted-by":"publisher","unstructured":"Wang Z, Wang A, Gong Z, Biviano I, Liu H, Hu J. Plasma claudin-3 is associated with tumor necrosis factor-alpha-induced intestinal endotoxemia in liver disease. Clin Res Hepatol Gastroenterol. 2019;43:410\u20136. https:\/\/doi.org\/10.1016\/j.clinre.2018.11.014.","DOI":"10.1016\/j.clinre.2018.11.014"},{"key":"4112_CR24","doi-asserted-by":"publisher","unstructured":"Wang C, Zai W, Zhao K, Li Y, Shi B, Wu M, Zhou X, Kozlowski M, Zhang X, Fang Z, Yuan Z. Potential role of liver-resident CD3\u2009+\u2009macrophages in HBV clearance in a mouse hepatitis B model. JHEP Reports: Innov Hepatol. 2024;7(4):101323. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101323.","DOI":"10.1016\/j.jhepr.2024.101323"},{"key":"4112_CR25","unstructured":"World Health Organization [WHO]. Hepatitis B. 2023. Available online at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b. Accessed 18 Jul 2023."},{"key":"4112_CR26","unstructured":"World Health Organization [WHO]. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: accountability for the global health sector strategies 2016\u20132021: actions for impact: web Annex 1: key data at a glance. Geneva: World Health Organization; 2021."},{"key":"4112_CR27","doi-asserted-by":"publisher","unstructured":"Xu XY, Wang Z, Ren S, Leng J, Hu JN, Liu Z, Chen C, Li W. Improved protective effects of American ginseng berry against acetaminophen-induced liver toxicity through TNF-\u03b1-mediated caspase-3\/-8\/-9 signaling pathways. Phytomedicine Int J Phytother Phytopharmacol. 2018;51:128\u201338. https:\/\/doi.org\/10.1016\/j.phymed.2018.09.234.","DOI":"10.1016\/j.phymed.2018.09.234"},{"key":"4112_CR28","doi-asserted-by":"publisher","unstructured":"Xu Y, Xue W, Gao H, Cui J, Zhao L, You C. Association of toll-like receptors single nucleotide polymorphisms with HBV and HCV infection: research status. PeerJ. 2022;10:e13335. https:\/\/doi.org\/10.7717\/peerj.13335.","DOI":"10.7717\/peerj.13335"},{"key":"4112_CR29","doi-asserted-by":"publisher","unstructured":"Yao J, Ji Y, Liu T, Bai J, Wang H, Yao R, Wang J, Zhou X. Single-Cell RNA sequencing shows T-Cell exhaustion landscape in the peripheral blood of patients with hepatitis B Virus-Associated Acute-on-Chronic liver failure. Gut Liver. 2024;18(3):520\u201330. https:\/\/doi.org\/10.5009\/gnl220449.","DOI":"10.5009\/gnl220449"},{"key":"4112_CR30","doi-asserted-by":"publisher","unstructured":"Yuan L, Zeng BM, Liu LL, Ren Y, Yang YQ, Chu J, Li Y, Yang FW, He YH, Lin SD. Risk factors for progression to acute-on-chronic liver failure during severe acute exacerbation of chronic hepatitis B virus infection. World J Gastroenterol. 2019;25:2327\u201337. https:\/\/doi.org\/10.3748\/wjg.v25.i19.2327.","DOI":"10.3748\/wjg.v25.i19.2327"},{"key":"4112_CR31","doi-asserted-by":"publisher","unstructured":"Yue B, Gao Y, Hu Y, Zhan M, Wu Y, Lu L. Harnessing CD8\u2009+\u2009T cell dynamics in hepatitis B virus-associated liver diseases: insights, therapies and future directions. Clin Translational Med. 2024;14(7):e1731. https:\/\/doi.org\/10.1002\/ctm2.1731.","DOI":"10.1002\/ctm2.1731"},{"key":"4112_CR32","doi-asserted-by":"publisher","unstructured":"Zhang GL, Zhao QY, Xie C, Peng L, Zhang T, Gao ZL. Elevated serum IgG levels positively correlated with IL-27 May indicate poor outcome in patients with HBV-related acute-on-chronic liver failure. J Immunol Res. 2019a;2019(1538439). https:\/\/doi.org\/10.1155\/2019\/1538439.","DOI":"10.1155\/2019\/1538439"},{"key":"4112_CR33","doi-asserted-by":"publisher","unstructured":"Zhang X, Wang P, Chen T, Yan W, Guan X, Shen G, Luo X, Wan X, Ning Q. Kctd9 deficiency impairs natural killer cell development and effector function. Front Immunol. 2019b;10:744. https:\/\/doi.org\/10.3389\/fimmu.2019.00744.","DOI":"10.3389\/fimmu.2019.00744"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04112-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04112-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04112-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:38:32Z","timestamp":1758879512000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04112-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4112"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04112-6","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of the First Hospital of Shanxi Medical University All experiments were performed in accordance with relevant guidelines and regulations such as the Declaration of Helsinki and written informed consents were signed by the patients and\/or guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"663"}}